Terran Biosciences is a biotech platform company devoted to the development of transformative therapeutics and technologies for patients with neurological and psychiatric diseases. Our portfolio includes a late-stage therapy for schizophrenia, late-stage selective serotonin 2A receptor antagonists, a drug design engine that has enabled first-in-class and best-in-class psychedelic therapies, and an AI-enabled imaging software platform.Our team consists of biopharma industry professionals and successful physician-entrepreneurs, and we are uniquely positioned to become a leader in the rapidly growing renaissance in neuroscience.